Gastric ulcers: investigations and treatment.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001464:Barium; D001729:Bismuth / Q000627:therapeutic use*; D002229:Carbenoxolone / Q000627:therapeutic use; D004724:Endoscopy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D013392:Sucralfate
D000305:Adrenal Cortex Hormones; D000863:Antacids; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D011453:Prostaglandins; D001464:Barium; D013392:Sucralfate; D000535:Aluminum; D002229:Carbenoxolone; D001729:Bismuth